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Summary . Investigations on animal models
demonstrated that changes of sialic acid (SA)
expression, particularly the polymeric form, in the
skeletal muscle during embryonic and post-natal
development seem to be related to muscle differentiation
and functionality onset. The aim of this study was to
evaluate the monomeric and polymeric SA expression in
human skeletal muscle during early stages of fetal
development, when important morphofunctional events
occur. Specimens of fetal skeletal muscle from limb,
between 9 and 12 weeks of gestation (wg), were
obtained from 19 pregnant women. To investigate some
morphofunctional features occurring during this
development period, haematoxylin-eosin staining, tunel
assay and immunohistochemistry for connexin-43
(Cx43) and parvalbumin were performed. SA expression
and characterization was evaluated using lectin
histochemistry (MAA, SNA, PNA, SBA, DBA),
associated with enzymatic and chemical treatments.
Polysialic acid (PSA) expression was also evaluated
using immunohistochemistry. The results showed
apoptotic myotubes between 9 and 10.5 wg,
disappearing from 11 wg; Cx43 was more abundant in
myotubes/myoblasts between 9 and 9.5 wg, decreasing
and/or disappearing from 10 wg and parvalbumin was
present in myotubes between 10 and 10.5 wg. PSA was
revealed in myotubes/myoblasts from 9 to 10.5 wg; from
11 wg it was reduced or disappeared. Monomeric SA
appeared in myotubes/myoblasts from 10 wg, increasing
successively; acetylated SA was present from 11 wg.
These findings demonstrated that changes in expression
of various types of SA, occurring in human fetal skeletal
muscle during early development, seem to be related to
some morphofunctional aspects distinctive of this
organogenesis crucial period.
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Introduction
During embryogenesis, limb musculature of
vertebrates arises from precursor cells migrating from
the lateral dermomyotome. The development of this
migratory myogenic lineage depends on the formation of
a cell precursor pool in the somite, delamination and
migration to the correct target sites, and activation of the
myogenic program in the limb region (Buckingham et
al., 2003; Olguin et al., 2003). Among the various
molecules implied in normal myogenesis and in the
normal structure and functionality of the adult muscle,
the sialic acids (SAs) seem to play an important role
(Covault et al., 1986; Fredette et al., 1993; Brusés et al.,
1995; Rafuse and Landmesser, 1996; Allan and Greer,
1998; Grow and Gordon, 2000; Hoyte et al., 2002;
McDearmon et al., 2003; Suzuki et al., 2003; Johnson et
al., 2004; Combs and Ervasti, 2005; Nilsson et al., 2010;
Schwetz et al., 2011). 
SAs are a family of large size negatively charged
nine carbon 2-keto-3-deoxy sugars, frequently located in
terminal position in glycan chains of many
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glycoconjugates, with different structure and linkage
type to the penultimate sugar acceptor. Because of these
characteristics, pivotal biological functions have been
proposed for the SAs, such as maintaining membrane
stability and modulating various intercellular and
intermolecular phenomena (Gabrielli et al., 2004; Varki,
2007; Accili et al., 2008; Schauer, 2009). The most
common structural modification is the addition of one or
more O-acetyl esters to hydroxyl groups (Angata and
Varki, 2002; Schauer, 2004; Varki and Schauer, 2009).
Linkage type can be α2-3 or α2-6 with galactose or N-
acetyl-galactosamine, and α2-8 to form polysialic acid
(PSA). 
Studies performed on normal skeletal muscle,
mostly in animal models, showed that SAs are implied in
the functionality of various glycosylated molecules,
involved in fiber structure, excitability, contractility and
neuromuscular junction (Hoyte et al., 2002; McDearmon
et al., 2003; Johnson et al., 2004; Combs and Ervasti,
2005; Nilsson et al., 2010; Schwetz et al., 2011). The
role of SA in skeletal muscle has also been widely
investigated, both in animal models and in human,
studying the Hereditary Inclusion Body Myopathy
(HIBM), a genetic pathology leading to muscular
weakness and atrophy. HIBM is due to mutations of
UDP-N-acetylglucosamine 2-epimerase/N-acetyl-
mannosamine kinase (GNE) gene involved in SA
biosynthesis (Huizing and Krasnewich, 2009). Data
demonstrated that hyposialylation of glycosylated
molecules, important for correct structure and
functionality of skeletal muscle tissue, seems to alter
their activity (Saito et al., 2004; Tajima et al., 2005;
Broccolini et al., 2008, 2009, 2010, 2011; Jay et al.,
2008; Broccolini et al., 2009; Huizing and Krasnewich,
2009; Jay et al., 2009; Nilsson et al., 2010; Voermans et
al., 2010; Broccolini and Mirabella, 2015). 
Expression changes of SA in skeletal muscle during
aging were observed mostly in animal models. These
seem to be related to metabolism alteration of muscle
fibers (O’Connell et al., 2008) and to influence the re-
innervation process, after experimental denervation
(Olsen et al., 1995; Rønn et al., 2000). Our recent
investigation on human skeletal muscle tissue showed
expression changes of various types of SAs during aging
that could be related to alterations of important
molecules implied in the normal morphology and
functionality of this organ (Marini et al., 2014). 
To our knowledge, investigations in animal models
have only been performed on the expression of SA, in
particular PSA, in the skeletal muscle during embryonic
and post-natal development. These studies showed that
changes in expression of this anionic molecule seem to
be related to differentiation and onset of the muscle
functionality (Covault et al., 1986; Fredette et al., 1993;
Brusés et al., 1995; Rafuse and Landmesser, 1996; Allan
and Greer, 1998; Grow and Gordon, 2000; McDearmon
et al., 2003; Suzuki et al., 2003). Some data, both in
animals and humans, are also available in the literature,
not directly on SA expression but on GNE enzyme. It
seems to be essential for fetal skeletal muscle
development (Krause et al., 2004; Milman et al., 2011;
Daya et al., 2014).
In this study, we characterized monomeric and
polymeric SAs widely and evaluated their expression in
human skeletal muscle tissue from upper and lower
limbs during early stages of fetal development, between
9 and 12 weeks of gestation (wg). During this period,
fundamental morphofunctional events, such as
secondary and mature myotubes formation, apoptosis to
regulate muscle cell population, innervation,
neuromuscular junction formation and contractility,
occur (Fenichel, 1965; Fidziańska and Goebel, 1991;
Fidziańska, 1996; Standring, 2009). Therefore, the aim
of this investigation was to highlight the role of these
molecules in the morphological differentiation and




Specimens of upper and lower limb fetal skeletal
muscle, from 9 to12 wg, were obtained from 19 pregnant
women who underwent a therapeutic or voluntary
abortion (9 wg n=3; 9.4 wg n=3; 9.5 wg n=2; 10 wg
n=2; 10.5 wg n=2; 11 wg n=1; 11.3 wg n=2; 11.5 wg
n=1; 12 wg n=3). Informed consent was obtained from
each woman. The use of human fetal tissues for research
purposes was approved by the Ethical Committee for
investigation in humans of the Azienda Ospedaliero-
Universitaria Careggi, Florence, Italy (protocol n° 6783-
04). The fetal muscle samples were collected and
prepared by a stereomicroscope provided with a
millimetric scale. 
Muscle samples were fixed in formalin solution,
routinely processed, paraffin-embedded and cut in 5 μm-
thick sections, for histochemical and immunohisto-
chemical studies.
Morphofunctional  changes  of  human  skeletal muscle  in
early fetal development
To investigate some morphofunctional events
occurring during the early development of skeletal
muscle, the following stainings and methods were
performed: haematoxylin-eosin, TUNEL assay,




Briefly, apoptotic cells were identified using
FragelTM DNA Fragmentation Detection Kit,
Fluorescent-TdT Enzym (Cat# QIA21, Calbiochem, San
Diego, CA, USA). Sections from all fetal samples were
deparaffinised, rehydrated and subjected to the TUNEL
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assay according to the manufacturer’s protocol, as
previously described (Mencucci et al., 2013, 2015). The
slides were evaluated and photographed using a Nikon
Microphot-FXA microscope (Nikon).
Immunohistochemistry for connexin-43 and parvalbumin 
Deparaffinised and rehydrated tissue sections from all
fetal samples were processed using standard
immunohistochemical procedures, as previously described
(Mencucci et al., 2013, 2015). Briefly, sections were
treated with hydrogen peroxide 3% solution for 15
minutes at room temperature to block endogenous
peroxidase activity. Sections were then washed and
incubated with Ultra V block (UltraVision Large Volume
Detection System Anti-Polyvalent, HRP, catalogue
number TP-125-HL; LabVision, Fremont, CA, USA) for
10 minutes at room temperature according to the
manufacturer’s protocol. After blocking non-specific site
binding, slides were incubated overnight at 4°C with anti-
human connexin-43 (Cx43) (1:100 dilution; Sigma-
Aldrich, Saint Louis, MO, USA) and parvalbumin
(1:10,000 dilution; Sigma-Aldrich) mouse monoclonal
antibodies. The day after, tissue sections were rinsed in
PBS and incubated with biotinylated secondary antibodies
(Lab-Vision) for 10 minutes at room temperature and then
with the streptavidin-biotin peroxidase (Lab-Vision) for
10 minutes at room temperature. Immunoreactivity was
developed using 3,3’-diaminobenzidine tetrahydro-
chloride (DAB) (Sigma-Aldrich) as chromogen. All
sections were treated with the same batch for each
antibody to eliminate inter-batch variations. Sections not
exposed to primary antibodies or incubated with isotype-
and concentration-matched non-immune mouse IgG
(Sigma-Aldrich) were included as negative controls for
antibody specificity. The slides were evaluated and




Two methods for lectin histochemistry were used:
the ‘direct’ and the ‘indirect’ techniques. In the ‘direct’
technique, Maackia amurensis agglutinin (MAA) and
Sambucus nigra agglutinin (SNA) were used to identify
SAs linked α2-3 and α2-6 to galactose or galactosamine,
respectively (Shibuya et al., 1987; Wang et al., 1988;
Gabrielli et al., 2004; Adembri et al., 2011, 2014; Marini
et al., 2011, 2014). In the second method peanut
agglutinin (Arachis  hypogaea) (PNA), soybean
agglutinin (Glycine maximus) (SBA) and Dol ichos
biflorus agglutinin (DBA) combined with neuraminidase
digestion, deacetylation and differential oxidation to
reveal acetylic groups, were used to investigate the
expression of SAs linked to D-Gal(β13)-D-GalNAc,
to α/βD-GalNAc >D-Gal and αD-GalNAc respectively,
and the structure of SAs (Gabrielli et al., 2004; Adembri
et al., 2011, 2014; Marini et al., 2011, 2014). Table 1
summarizes lectins and their specific sugar residues.
MAA and SNA were digoxigenin (DIG) labeled
lectins (Roche Diagnostic, Mannheim, Germany). PNA,
SBA and DBA were horseradish peroxidase (HRP)
conjugated lectins (Sigma-Aldrich). 
DIG-label l ed  l ecti ns.  The direct technique was
performed as previously described (Adembri et al.,
2014; Marini et al., 2014). Briefly, deparaffinised and
rehydrated tissue sections from all fetal samples were
treated with 20% acetic acid, to inhibit the endogenous
alkaline phosphatase, then treated with 10% blocking
reagent in TBS to reduce the background labelling.
Afterward, sections were washed in TBS and rinsed in
Buffer 1, then incubated in DIG-labelled lectins diluted
in Buffer 1 (1 μL/mL and 5 μL/mL for SNA and MAA
respectively) for 1 hour at room temperature. Sections
were then rinsed in TBS, incubated with anti-
digoxigenin conjugated with alkaline phosphatase
diluted in TBS and washed in TBS. Labelling of the sites
containing bound lectin-digoxigenin was obtained by
incubating slides with Buffer 2, containing nitroblue
tetrazolium (NBT)/X-phosphate (Roche Diagnostics,
Mannheim, Germany).
HRP-conjugated  lectins. The indirect technique was
performed as previously described (Adembri et al.,
2014; Marini et al., 2014). Briefly, deparaffinised and
rehydrated tissue sections from all fetal samples were
treated with 3% hydrogen peroxide to inhibit the
endogenous peroxidase, rinsed in distilled water and
treated with 0.1% bovine serum albumin (BSA) in TBS
to reduce the background labelling. Sections were then
incubated for 30 min at room temperature in HRP-
conjugated lectins solution in TBS (25 μL/mL, 20
μL/mL and 25 μL/mL for PNA, SBA and DBA
respectively). Then sections were rinsed in TBS.
Visualization of the sites containing bound lectin-HRP
was achieved by incubating slides in DAB (Sigma-
Aldrich). 
Enzymatic and chemical  treatments. Treatments were
carried out as previously performed (Adembri et al.,
2014; Marini et al., 2014). Briefly, mono and polymeric
SA was removed by pretreating sections for 18 hours at
37°C in a solution of sodium acetate buffer 0.25M, pH
5.5, containing 0.1 unit/ml sialidase (Type X from
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Table 1. Sugar residues binding specificity of lectin.
Lectin Abbreviation Sugar residues binding specificity
Maackia amurensis agglutinin MAA Neu5Ac(α23)Gal
Sambucus nigra agglutinin SNA Neu5Ac(α26)Gal/GalNAc
Peanut agglutinin PNA D-Gal(β13)-D-GalNAc
Soybean agglutinin SBA α/β-D-GalNAc > D-Gal
Dolichos biflorus agglutinin DBA α-D-GalNAc
Clostridium perfringens; Sigma-Aldrich), 50mM CaCl2and 154mM NaCl, before staining with PNA, SBA and
DBA. Deacetylation was performed by incubating
sections with 0.5% KOH in 70% ethanol for 30 minutes
at room temperature. This treatment renders SA residues,
containing acetylic groups on C4 of the pyranose ring,susceptible to neuraminidase digestion. For differential
oxidation, 1 mM aqueous periodic acid (1 mM PO, mild
oxidation) and 44 mM aqueous periodic acid (44 mM
PO, strong oxidation) were used. Mild oxidation
abolishes the staining with neuraminidase/
PNA-SBA-DBA or KOH/neuraminidase/PNA-SBA-
DBA when SA does not contain C7-and/or C8- and/orC9-O-acetyl groups in the side-chain. Strong oxidationaffects SA side-chains lacking acetyl substituents in C9as well as penultimate β-galactose linked via α2-6, but
not if C9 acetylated SAs linked α2-3 bound to thepenultimate β-galactose are present (Gabrielli et al.,
2004; Adembri et al., 2011, 2014; Marini et al., 2011,
2014). 
Controls. Controls for lectin specificity included
substitution of lectin-conjugates with the respective
unconjugated lectins or preincubation of lectins with the
corresponding hapten sugars (concentration of 0.1-0.5 M
in TBS). Control of sialidase digestion was made by
incubation of the sections with enzyme-free buffer. The
efficacy of digestion was tested treating adjacent
sections, with and without prior deacetylation, with the
enzyme solution and then labeling them with MAA and
SNA. Some control sections were treated with a
desulfation procedure that eliminates sulfated groups
present on the carbohydrate chains interfering with lectin
binding (Gabrielli et al., 2004; Adembri et al., 2011,
2014; Marini et al., 2011, 2014).
PSA immunohistochemistry
Immunohistochemical technique was performed to
detect PSA, as previously described (Marini et al.,
2014). Briefly, endogenous peroxidase was blocked
incubating the deparaffinised and rehydrated tissue
sections from all fetal samples in 0.3% hydrogen
peroxide for 10 min. Sections were rinsed in distilled
water, treated with blocking serum for 15 min to reduce
non-specific reactions and incubated with polySia-
specific mAb 735 (kindly provided by Rita Gerardy-
Schahn, Hannover Medical School, Hannover,
Germany) (40 μg/ml in phosphate-buffered saline and
0.1% bovine serum albumin) overnight at 4°C. Then,
sections were rinsed in PBS and incubated with
biotinylated secondary antibodies (Lab-Vision) for 10
minutes at room temperature and then with the
streptavidin-biotin peroxidase (Lab-Vision) for 10
minutes at room temperature. The development of the
product was evidenced incubating sections in DAB
(Sigma-Aldrich) as chromogen.
Control. Serial muscle sections were pretreated with
sialidase, used also for lectin histochemistry, before
staining with mAb 735 and followed the same
procedure, for negative controls.
All the slides were evaluated and photographed
using a Nikon Microphot-FXA microscope (Nikon,
Tokyo, Japan). 
Evaluation  of  lectin  histocheistry  and  immunohisto-
chemistry reactivity
In each section (3 sections for each specimen),10
random 600625 μm2 optical square fields (40x
objective), were examined and scored for location of
lectin reactivity and immunoreactivity for Cx43,
parvalbumin and PSA. In addition, two types of analyses
were performed to evaluate the reactivity intensity: an
arbitrary analysis (0: no reactivity; 0-1: very weak
reactivity; 1: weak reactivity; 1-2: weak/moderate
reactivity; 2: moderate reactivity; 2-3: moderate/strong
reactivity; 3: strong reactivity; 3-4 very strong reactivity)
and a quantitative analysis, measuring the average
optical density (OD) on regions of interest (ROI, 40 µm2
area) of light microscopy images, using ImageJ National
Institute of Health (NIH, Bethesda, MD, USA) software.
For this analysis, measured values were normalized to
background [(OD-ODbkg)/ODbkg]. In each experiment,
at least 8 regions of interest in 10 different optical fields
were analyzed. 
Statistical analysis
All values were tested for normality distribution and
were expressed as mean ± standard error of the mean
(SEM). Analysis of variance (ANOVA), followed by
Tukey’s multiple comparison test to assess differences
among samples was used. Data analysis was performed
using GraphPad Prism 5.0 (GraphPad Software, La Jolla,




Haematoxilyin-eosin staining showed from 9 to 10.5
wg, both in upper and lower limb, many primary
myotubes surrounded by secondary myotubes and
myoblasts (Fig. 1A,B); from 10 wg some secondary
myotubes began to appear separate from primary ones.
From 11 wg secondary myotubes increased in number
and were separated from primary ones (Fig. 1C). These
data are in accord with previous morphological
observations on human fetal skeletal muscle (Fidziańska,
1991).
TUNEL assay (Fig. 2)
TUNEL assay demonstrated the presence of
apoptotic myotubes between 9 (Fig. 2A) and 10.5 wg
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(Fig. 2B) both in upper and lower limb; no apoptosis
was revealed from 11 wg (Fig. 2C). The apoptotic
process occurs to reduce the final number of muscle
functional fibers (Fidziańska, 1996).
Immunohistochemistry and lectin histochemistry
No differences in reactivity location and intensity for
immunohistochemistry and lectin histochemistry were
observed in the samples between upper and lower limb,
and between 9 and 9.5, 10 and 10.5, 11 and 12 wg. So,
they were included in three groups as reported in table 2:
group 1 (9-9.5 wg), group 2 (10-10.5 wg) and group 3
(11-12 wg). 
Cx43 and parvalbumin immunoreactivity (Fig. 3)
Immunohistochemistry for Cx43, the principal
protein in gap junction, showed reactivity at the plasma
membrane of the myotubes, in the contact sites with
myoblasts, and on the whole plasma membrane of
myoblasts in group 1 (Fig. 3A). Very weak/absent
reactivity in myoblasts and absent in myotubes of groups
2 and 3 was observed (Fig. 3B). 
Parvalbumin immunoreactivity, cytoplasm protein
binding ions Ca, involved in muscle relaxation, was
detected in the cytoplasm and nucleoplasm of the
myotubes with weak/moderate intensity only in group 2
(Fig. 3C,D).
Lectin reactivity location and intensity (Table 2;
Figs. 4-6)
MAA and SNA. Both lectins did not react in group 1
(Table 2; Fig. 4A,D). MAA and SNA reactivity appeared
in plasma membrane/basement membrane and
cytoplasm of myotubes and myoblasts of group 2 (Table
2; Fig. 4B,E). Reactivity increased in group 3 (Table 2;
Fig. 4C,F). Quantitative analysis showed a significantly
higher intensity of reactivity in the myotubes and
myoblasts of group 3 compared to group 2 (P<0.05)
(Fig. 4G). 
These reactivities indicated the appearance of
monomeric SAs both linked α2-3 and α2-6 to galactose
or galactosamine in group 2, increasing in group 3.
PNA and PNA with enzymatic and chemical  treatments.
PNA reactivity was moderate in plasma
membrane/basement membrane, and very weak in
cytoplasm of the myotubes and myoblasts in groups 1
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Fig. 1. Haematoxylin-eosin staining in fetal skeletal muscle. Representative micrographs of muscle samples from the lower limb of fetuses of 9.4 wg
(A), 10 wg (B) and 12 wg (C). At 9.4 (A) and 10 (B) wg many primary myotubes (arrows) surrounded by secondary myotubes (arrow heads) and
myoblasts (asterisks) are observable; at 10 wg some secondary myotubes are separate from primary ones. Secondary myotubes (arrows head) appear
in higher number at 12 wg and are mostly separated from primary myotubes (arrows) (C). Scale bar: 25 µm.
Table 2. SA lectin reactivity and immunoreactivity in human fetal
skeletal muscle.
Group1 Group2  Group3 
(9-9.5 wg) (10-10.5 wg) (11-12 wg)
MAA 0 1pm/bm 0-1c 1-2pm/bm 1c
SNA 0 1pm/bm 0-1c 1-2pm/bm 1c 
PNA 2pm/bm 0-1c 2pm/bm 0-1c 1pm/bm 0-1c 
Neu/PNA 3pm/bm 1c 3pm/bm 1c 3pm/bm 1c 
KOH/Neu/PNA 3pm/bm 1c 3pm/bm 1c 3-4pm/bm 3c
1mMPO/Neu/PNA 2pm/bm 0-1c 2pm/bm 0-1c 2-3pm/bm 1c
1mMPO/KOH/Neu/PNA 2pm/bm 0-1c 2pm/bm 0-1c 3pm/bm 1c 
44mMPO/Neu/PNA
44mMPO/KOH/Neu/PNA 0 0 0-1
SBA 2pm/bm 1c 2pm/bm 1c 1-2pm/bm 0-1c 
Neu/SBA 2pm/bm 1c 3pm/bm 1-2c 3pm/bm 2c 
KOH/Neu/SBA 2pm/bm 1c 3pm/bm 1-2c 3-4pm/bm 3c 
1mMPO/Neu/SBA
1mMPO/KOH/Neu/SBA 2pm/bm 1c 2pm/bm 1c 1-2pm/bm 0-1c 
44mMPO/Neu/SBA
44mMPO/KOH/Neu/SBA 0 0 0-1
DBA 2pm/bm 1c 2pm/bm 1 c 1-2pm/bm 0-1c 
Neu/DBA 2pm/bm 1c 2-3pm/bm 1-2c 2-3pm/bm 1-2c 
KOH/Neu/DBA 2pm/bm 1c 2-3pm/bm 1-2c 3pm/bm 2c 
1mMPO/Neu/DBA
1mMPO/KOH/Neu/DBA 2pm/bm 1c 2pm/bm 1c 1-2pm/bm 0-1c 
44mMPO/Neu/DBA
44mMPO/KOH/Neu/DBA 0 0 0-1 
polySia-specific mAb 3pm§ 1c 2pm§ 1c 0-1/0pm c
0: no reactivity; 0-1: very weak reactivity; 1: weak reactivity; 1-2:
weak/moderate reactivity; 2: moderate reactivity; 2-3: moderate/strong
reactivity; 3: strong reactivity; 3-4: very strong reactivity; §: 2 (group 1), 1
(group 2) in no contact sites; wg: weeks of gestation; pm: plasma
membrane of myotubes and myoblasts; bm: basement membrane; c:
cytoplasm of myotubes and myoblasts.
and 2 (Table 2; Fig. 5 insets A,B); in group 3 lectin
reacted more weakly with respect to the other groups
(Table 2; Fig. 5 inset C). After neuraminidase digestion
PNA reactivity was strong in plasma membrane/
basement membrane and weak in cytoplasm of the
myotubes and myoblasts of groups 1, 2 and 3 (Table 2;
Fig. 5A-C).
After deacetylation/neuraminidase treatment, a
stronger reactivity was observed in the compartments of
the myotubes and myoblasts with respect to
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Fig. 3. Cx43 and parvalbumin immunoreactivity in fetal skeletal muscle. A. Representative micrograph of a group 1 muscle sample from the upper limb
of fetus of 9.4 wg for Cx43. B, D. Representative micrograph of a group 3 muscle sample from the upper limb of fetus of 12 wg for Cx43 and
parvalbumin respectively. C. Representative micrograph of a group 2 muscle sample from the upper limb of fetus of 10 wg for parvalbumin. Cx43
immunoreactivity is observable at the plasma membrane of the myotubes (arrows), on the contact sites with myoblasts, and on the whole plasma
membrane of myoblasts (asterisks) in group 1 sample (A); very weak/absent reactivity in myoblasts (asterisks), absent in myotubes (arrows) of group 3
sample is detectable (B). Parvalbumin immunoreactivity is present in the cytoplasm and nucleoplasm of the myotubes with weak/moderate intensity in
group 2 sample (C) and absent in group 3 sample (D). Scale bar: 25 µm.
Fig. 2. TUNEL assay in fetal skeletal muscle. Representative micrographs of muscle samples from the upper limb of fetuses of 9.5 wg (A), 10.5 wg (B)
and 11.5 wg (C). Apoptotic myotubes are observable at 9.5 (A) and 10.5 (B) wg (arrows); no apoptosis is visible at 11.5 wg (C). Scale bar: 50 µm.
neuraminidase treatment only in group 3 (Table 2; Fig.
5D-F).
After mild oxidation/neuraminidase treatment, with
and without deacetylation, PNA reactivity appeared the
same in the compartments of myotubes and myoblasts of
groups 1 and 2 compared to PNA reactivity without
treatments (Table 2; Fig. 5G,H); in group 3, after mild
oxidation, neuraminidase/PNA reactivity with and
without deacetylation was weaker compared to
neuraminidase/PNA and deacetylation/neuraminidase-
PNA reactivity respectively, and stronger with respect to
PNA without treatments (Table 2; Fig. 5I).
After strong oxidation/neuraminidase treatment,
with and without deacetylation, absent or very weak
reactivity was observed in all the muscle elements of the
three groups with respect to PNA reactivity with and
without other treatments (Table 2).
Quantitative analysis showed PNA reactivity
significantly higher in all the myotubes/myoblasts of
groups 1 and 2 with respect to group 3. After
neuraminidase digestion, significantly higher reactivity
intensity in the muscle elements of all groups compared
to reactivity with PNA only was observed. After
deacetylation/neuraminidase treatment, reactivity
intensity was significantly higher in group 3 compared to
groups 1 and 2, and with respect to reactivity after
neuraminidase digestion only in group 3. Reactivity
intensity with mild oxidation/neuraminidase/PNA, with
and without deacetylation, in groups 1 and 2 appeared
significantly lower with respect to neuraminidase/PNA,
with and without deacetylation respectively; in group 3
mild oxidation/neuraminidase/PNA, with and without
deacetylation, was lower compared to neuraminidase/
PNA reactivity, with and without deacetylation
respectively, and higher with respect to PNA without
treatments. In addition, after mild oxidation with and
without deacetylation treatment, reactivity in group 3
appeared significantly higher with respect to groups 1
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Fig. 4. MAA and SNA reactivity in fetal skeletal muscle. A, D. Representative micrograph of a group 1 muscle sample from the lower limb of fetus of 9.4
wg. B, E. Representative micrograph of a group 2 muscle sample from the lower limb of fetus of 10.5 wg. C, F. Representative micrograph of a group 3
muscle sample from the lower limb of fetus of 11.3 wg. G. Quantitative analysis in groups 1, 2 and 3 for MAA and SNA (data are the mean of OD
values of all the samples in each study group). No reactivity is observable for both lectins in group 1 sample (A) (D). MAA and SNA reactivity is
detectable in plasma membrane/basement membrane and cytoplasm of myotubes (arrows) and myoblasts (asterisks) of group 2 samples (B) (E);
reactivity appears increased in group 3 (C) (F). Quantitative analysis confirms that MAA and SNA reactivity intensity in myotubes/myoblasts is
significantly higher in group 3 compared to group 2 (G) (*: P<0.05). Scale bar: 25 µm.
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Fig. 5. PNA with and without treatments reactivity in fetal skeletal muscle. A-C. Neuraminidase/PNA reactivity. Insets A-C. PNA reactivity. 
D-F. KOH/neuraminidase/PNA reactivity. G-I. OD1/KOH/neuraminidase/PNA reactivity, in groups 1, 2 and 3 muscle samples from the lower limb of
fetuses of 9.4, 10.5 and 11.3 wg respectively. J. Quantitative analysis in groups 1, 2 and 3 (data are the mean of OD values of all the samples in each
study group). PNA reactivity is observable in plasma membrane/basement membrane, and in cytoplasm of the myotubes (arrows) and myoblasts
(asterisks) in all the group samples (insets A-C); in group 3 reactivity appears weaker (inset C). After neuraminidase digestion PNA reactivity is stronger
in all the groups (A-C). After deacetylation/neuraminidase treatment, a stronger reactivity in the compartments of the myotubes (arrows) and myoblasts
(asterisks) with respect to neuraminidase treatment only in group 3 is observable (D-F). After mild oxidation/neuraminidase treatment, with
deacetylation, PNA reactivity appears the same in the compartments of myotubes (arrows) and myoblasts (asterisks) of groups 1 and 2 compared to
PNA reactivity without treatments (G, H); in group 3 reactivity is weaker compared to deacetylation/neuraminidase reactivity, and stronger with respect
to PNA without treatments (I). Quantitative analysis (J) shows PNA reactivity significantly higher in all the myotubes/myoblasts of groups 1 and 2 with
respect to group 3 (*: P<0.05). After neuraminidase digestion, a significantly higher reactivity intensity in the muscle elements of all groups is shown
compared to reactivity with PNA only (§: P<0.05). After deacetylation/neuraminidase treatment, reactivity intensity is significantly higher in group 3
compared to groups 1 and 2 (°: P<0.05) and, with respect to reactivity after neuraminidase digestion, only in group 3 (#: P<0.05). Reactivity intensity
with neuraminidase/PNA and deacetylation-neuraminidase/PNA in groups 1, 2 and 3 is signif icantly higher with respect to mild
oxidation/neuraminidase/PNA, with and without deacetylation (@: P<0.05); in group 3 mild oxidation/PNA reactivity intensity, with and without
deacetylation, is higher with respect to that in groups 1 and 2 and compared to PNA reactivity without treatments in group 3 (^: P<0.05). Strong
oxidation/neuraminidase/PNA reactivity (with and without deacetylation) is significantly lower compared to all the other treatments and without
treatments in both groups (+: P<0.05). Scale bar: A, B, D, E, G, H, 25 µm; C, F, I, 20 µm; insets A-C, 60 µm.
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Fig. 6. SBA and DBA with and
without treatments reactivity in fetal
skeletal muscle. A, B.
Neuraminidase/SBA reactivity.
Insets A, B. SBA reactivity. C, D.
KOH/neuraminidase/SBA reactivity.
E, F. Neuraminidase/DBA reactivity.
Insets E, F. DBA reactivity. G, H.
KOH/neuraminidase/DBA reactivity,
in groups 2 and 3 muscle samples
from the lower limb of fetuses of
10.5 and 11.3 wg respectively. I, J.
Quantitative analysis in groups 1, 2
and 3 for SBA and DBA respectively
(data are the mean of OD values of
all the samples in each study group).
SBA (insets A, B) and DBA (insets
E, F) reactivity is observable in
plasma membrane/basement
membrane and in cytoplasm of
myotubes (arrows) and myoblasts
(asterisks) of groups 2 and 3
samples; reactivity is weaker in
group 3. After neuraminidase
digestion, SBA (A, B) and DBA (E,
F) reactivity appears stronger in
myotubes (arrows) and myoblasts
(asterisks) of groups 2 and 3,
compared to SBA and DBA
reactivity; only in group 3 a stronger
reactivity is observable after
neuraminidase treatment with
deacetylation compared to without
deacetylation (C, D, G, H).
Quantitative analysis shows
statistically significant higher SBA (I)
and DBA (J) reactivity in the
myotubes/myoblasts of groups 1 and
2 with respect to group 3 (*: P<0.05).
Significantly higher reactivity
intensity is observable after
neuraminidase treatment with and
without deacetylation in all the
muscle elements of groups 2 and 3
with respect to reactivity with SBA
and DBA only (§: P<0.05), and in the
same groups compared to group 1
(°: P<0.05); in group 3, after
neuraminidase treatment with
deacetylation, reactivity is
significantly higher compared to that
without deacetylation (#: P<0.05).
Reactivity intensity of mild
oxidation/neuraminidase/SBA-DBA,
with and without deacetylation, is
significantly lower with respect to
neuraminidase/SBA-DBA, with and
without deacetylation respectively, in
all the muscle elements of groups 2
and 3 (@: P<0.05). Strong
oxidation/neuraminidase/SBA-DBA
reactivity (with and without
deacetylation) is significantly lower
compared to all the other treatments
and without treatments in all the
groups (^: P<0.05). Scale bar: A, C,
E, G, 25 µm; B, D, F, H, 20 µm;
insets A, B, E, F, 60 μm.
and 2. Strong oxidation/neuraminidase/PNA reactivity
(with and without deacetylation) was significantly lower
compared to all the other treatments and without
treatments in all the groups (P<0.05) (Fig. 5J).
Altogether, the results of PNA reactivity indicated
the presence of SA linked to D-Gal(β13)-D-GalNAc
in groups 1 and 2, increasing in group 3. In addition, SA
acetylated in C4, in C7 and/or C8 and/or C9 linked via
α2-6 was present in group 3 only.
SBA and DBA, SBA and DBA wi th enzymatic and
chemical   treatments. SBA and DBA reactivity was
moderate in plasma membrane/basement membrane and
weak in cytoplasm of myoblasts/myotubes in groups 1
and 2 (Table 2; Fig. 6 insets A,E); reactivity was weaker
in group 3 (Table 2; Fig. 6 insets B,F). After
neuraminidase digestion, SBA and DBA reactivity was
stronger in all the muscle compartments of groups 2 and
3 (Table 2; Fig. 6A,B,E,F); only in group 3 a stronger
reactivity was observed after neuraminidase treatment
with deacetylation compared to treatment without
deacetylation (Table 2; Fig. 6C,D,G,H). 
After mild oxidation/neuraminidase treatments, with
and without deacetylation, the same reactivity was
detected in myotubes/myoblasts of group 1 with respect
to reactivity with lectins without treatments or with the
other treatments; in groups 2 and 3, after mild
oxidation/neuraminidase treatments reactivity was the
same with respect to lectins without treatments, but
weaker with respect to the other treatments (Table 2).
Strong oxidation treatment, with and without
deacetylation, abolished or strongly decreased the
reactivity in all the components of the three groups
(Table 2).
Quantitative analysis showed statistically significant
higher SBA and DBA reactivity in all the
myotubes/myoblasts in groups 1 and 2 with respect to
group 3. Significantly higher reactivity intensity was
also observed after neuraminidase treatment with and
without deacetylation in the muscle elements of groups 2
and 3 with respect to reactivity with SBA and DBA only,
and in the same groups compared to group 1. In group 3,
after neuraminidase treatment with deacetylation,
reactivity was significantly higher with respect to that
without deacetylation. In all the muscle elements of
groups 2 and 3, mild oxidation/neuraminidase/SBA-
DBA reactivity intensity, with and without deacetylation,
appeared significantly lower with respect to
neuraminidase/SBA-DBA respectively, with and without
deacetylation (P<0.05). Strong oxidation/neura-
minidase/PNA reactivity (with and without de-
acetylation) was significantly lower compared to all the
other treatments and without treatments in all the groups
(P<0.05) (Fig. I, J).
Overall, the results of SBA and DBA reactivity
indicated the presence of SA linked to α and β D-
GalNAc in group 2 and, more abundant, in group 3;
acetylated SA in C4 was present only in group 3. C7
and/or C8 and/or C9 acetylic group in SA were absent in
all the groups.
Controls. Sections incubated with lectins and their
corresponding hapten sugars and sections incubated with
unconjugated lectins, were unstained. Sections incubated
1216
Sialic acids in human fetal skeletal muscle
Fig. 7. PolySia-specific mAb immuno-
reactivity in fetal skeletal muscle. 
A. Representative micrographs of groups
1, 2 and 3 muscle samples from the upper
limb of fetus of 9.4 wg (A), 10 wg (B) and
11.3 wg (C) respectively. D. Quantitative
analysis in groups 1, 2 and 3 (data are the
mean of OD values of all the samples in
each study group). Strong reactivity at the
plasma membrane in the contact sites
(thick arrows), moderate in the no contact sites (thin arrows) and weak in cytoplasm of myotubes and myoblasts (asterisks) in the group 1 sample (A) is
observable; weaker reactivity in myotubes and myoblasts, both in contact (thick arrows) and no contact sites (thin arrows) is detectable in group 2
sample (B); in group 3 sample no reactivity is visible (C). Quantitative analysis confirms significantly higher reactivity intensity in myotubes/myoblasts of
group1 with respect to groups 2 and 3 (*: P<0.05), and in group 2 compared to group 3 (§: P<0.05) (D). Scale bar: 25µm.
with enzyme-free buffer did not show any change in
lectin binding. Results of the efficacy of enzymatic
digestion were as expected. Desulfation procedure did
not prove to affect the subsequent lectin binding (data
not shown). 
Location and intensity of polySia-specific mAb
immunoreactivity (Table 2; Fig. 7)
Immunohistochemistry for PSA showed strong
reactivity at the plasma membrane in the contact sites,
moderate in the no contact sites and weak in cytoplasm
of all myotubes and myoblasts, in group 1 (Table 2; Fig.
7A). Weaker reactivity in myotubes and myoblasts was
observed in group 2 (Table 2; Fig 7B). In group 3 very
weak or absent reactivity was seen (Table 2; Fig 7C).
Quantitative analysis showed a significant lower
reactivity intensity in groups 2 and 3 with respect to
group 1 and in group 3 compared to group 2 (P<0.05)
(Fig. 7D). 
The results indicated presence of PSA in myoblast
and myotubes in groups 1 and 2, drastically decreased or
disappeared in group 3.
Controls. Sections pretreated with sialidase before
staining with mAb 735 showed no reactivity (data not
shown). 
Discussion
The present investigation showed for the first time
that changes in distribution and content of different types
of SAs in human fetal skeletal muscle tissue occur in
limb early myogenesis during a key development period,
comprised between 9 and 12 wg. We also demonstrated
that changes of some morphofunctional aspects such as
apoptosis, cell interaction, contractility-relaxation and
cell growth, seem to be associated with these differences
in SA expression. 
Our findings, arising from lectin direct method,
demonstrated the appearance of monomeric SAs linked
α2-3 to galactose (MAA) and α2-6 to galactose and/or
galactosamine (SNA), in plasma membrane/basement
membrane and cytoplasm of the myoblasts and
myotubes from 10 wg, increasing in the following ones.
Lectin indirect method with neuraminidase and chemical
treatments confirmed the presence of SAs linked to
galactose and galactosamine, in particular to D-
Gal(β13)-D-GalNAc (PNA), to α and β D-GalNAc
(SBA) and to α D-GalNAc (DBA), in plasma
membrane/basement membrane and cytoplasm of the
muscle elements from 10 wg. It is to be noted that SA
linked to D-Gal(β13)-D-GalNAc (PNA) was also
present from 9 wg in the plasma membrane/basement
membrane and cytoplasm of myotubes and myoblasts.
This is explained by the fact that PNA reactivity after
neuraminidase treatment can indicate indirectly also the
presence of PSA, as neuraminidase used in our
experiments removes SAs linked not only α2-3 and α2-6
but also α-2,8 (Marini et al., 2014). In addition, PSA
chain is mostly “primed” on an initiating SA residue
linked α2-3 to galactose (Varki and Schauer, 2009). The
apparent presence of PSA in basement membrane is due
to the fact that it is attached to the glycoprotein neural
cell adhesion molecule (NCAM), forming the complex
PSA-NCAM mostly, and projects into the extracellular
matrix. The presence of PSA in plasma membrane, in
particular in contact sites, and in cytoplasm of myotubes
and myoblasts from 9 to 9.5 wg was confirmed by
immunohistochemistry. From 10 to 10.5 wg PSA begins
to decrease and from 11 to 12 wg it is drastically reduced
or disappeared in all muscle elements. Another
noteworthy finding is the presence of acetylated SAs, in
particular those linked to galactose, but only from 11 to
12 wg. Therefore, PSA is present in early stages of
examined development period of muscle and
decreases/disappears with appearance of monomeric
SAs, which change their structure in a short time. 
Regarding morphofunctional changes investigated in
this study, we observed: i) apoptotic myotubes were more
evident between 9 and 10.5 wg, disappearing from 11
wg; ii) Cx43 was more abundant between 9 and 9.5 wg in
myotubes and myoblasts and particularly in contact sites,
drastically decreasing and/or disappearing from 10 wg;
iii) parvalbumin was present in cytoplasm and
nucleoplasm of myotubes only between 10 and 10.5 wg. 
It is known that PSA is in general overexpressed
during rat muscle development and decreases after
postnatal development (Olsen et al., 1995; Rønn et al.,
2000). In particular, studies on animal models in  vivo
and in vitro showed that PSA is transiently up-regulated
on myotubes undergoing separation during both primary
and secondary myogenesis, and is restricted to those
regions of primary and secondary myotube plasma
membrane, which are juxtaposed and about to separate.
This separation provides a signal to stop further
myoblast fusion too (Fredette et al., 1993; Allan and
Greer, 1998). It is to be kept in mind that not sialylated
NCAM seems to be involved in the beginning of
myoblast fusion (Suzuki et al., 2003). In addition, PSA-
NCAM is highly expressed also by axons throughout
nerve outgrowth up to its down-regulation once the
mature intramuscular branching pattern occurs and
secondary myogenesis is complete (Brusés et al., 1995;
Allan and Greer, 1998). It is interesting the hypothesis
that the close proximity of axons to newly forming
myotubes implicates axon-myotube communication in
triggering myotube formation and PSA-NCAM
expression (Allan and Greer, 1998). This is supported by
the demonstration that neuromuscular electrical activity
and myotube contractility positively regulate myotube
expression of PSA-NCAM in a mechanism involving an
influx of calcium and activation of protein kinase C
(Fredette et al., 1993; Rafuse and Landmesser, 1996).
Alternatively, physical contact between developing
myotubes could also be intimately correlated with PSA-
NCAM labelling, with the expression on primary and
secondary myotubes commencing upon initial contact
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and declining after separation. This contact-related
control may be mediated by a combination of inter-
myotube gap junctional communication, contact-
stimulated myotube surface receptor activity and/or
nerve-induced contractile activity (Allan and Greer,
1998). PSA on myotubes may even concentrate the
fibroblast growth factor (FGF) and present it to its
receptor, stopping myoblast fusion. It is known that FGF
inhibits myoblasts fusion (Suzuki et al., 2003). Our
findings on PSA partially adhere to those in the
literature: the presence of this molecule was observed,
although in smaller amount, in myotubes in the no
contact sites and in myoblasts too. In addition, it is
noteworthy that from 10 wg Cx43 drastically diminishes,
while parvalbumin appears, disappearing afterwards
suddenly in cytoplasm and nucleoplasm of myotubes.
Several studies, always in animal models, demonstrated
that Cx43 is the principal gap junction protein and plays
an important role in transferring signals involved in
correct myogenetic events, such as fusion of myoblasts
and coordinated maturation of contractile capabilities
(Araya et al., 2003, 2005; Anderson et al., 2006; Gorbe
et al., 2007; von Maltzahn et al., 2011). It has been
shown that parvalbumin is a relaxation factor in the
postnatal muscle, particularly in animals, acting as a
shuttle to the transfer of Ca2+ from myofibrils to the
cytoplasmic reticulum (Berchtold et al., 2000; Murphy et
al., 2012). Ca2+ is present also in the nucleoplasm of
every type of cell, and plays specific biological effects
such as activation of distinct genes, transcription factors
and intranuclear kinases and regulation of cell growth
(Resende et al., 2013). In addition, parvalbumin has been
used as a molecular tool buffering intracellular Ca2+ to
demonstrate that in nucleoplasm decrease of Ca2+ slows
cell growth (Resende et al., 2013). 
Altogether our results could indicate that a period of
isolation, of contractility stop and changes in various
biological processes in muscle elements occurs from 10
to 10.5 wg, in order to prepare for future morpho-
functional events, such as new innervation and/or
redistribution of nervous branching (already began about
at 8 wg), maturation of myofibrillar apparatus and other
maturative processes, leading to mature myotubes.
No data is present in the literature regarding
monoSA expression in embryonic skeletal muscle tissue.
Several investigations demonstrated in muscle cell
cultures and muscle adult normal and HIBM tissue the
importance of SA in functionality of skeletal muscle
glycoproteins such as α-dystroglycan and neprilysin.
The α-dystroglycan is a dystroglycan complex
glycoprotein, component of the dystrophin-glycoprotein
complex located in the sarcolemma of striated muscle
fibers. α-dystroglycan, binding to several extracellular
ligands, seems to play an important role in mechanical
protection of the sarcolemma against shear stresses
imposed during muscle contraction and in maintaining
sarcolemma integrity (Combs and Ervasti, 2005; Nilsson
et al., 2010). In addition, of note, SA in α -dystroglycan
seems to have a role in laminin-induced AChR
(acetylcholine receptor) clustering in neuromuscular
junctions (McDearmon et al., 2003). Neprilysin (NEP) is
a richly sialylated metallopeptidase of plasma membrane
that cleaves amyloid-β (Aβ) in various sites (Broccolini
and Mirabella, 2015). Moreover, neprilysin appears to
play in skeletal muscle a role during development/
regeneration, cleaving the insulin-like growth factor-I
(IGF-I) binding protein 5, thus modulating IGF-I/Akt
cellular survival pathway (Broccolini et al., 2006). It is
noteworthy that NEP is overexpressed during myotubes
formation, decreasing in those mature at the end of the
differentiation processes (Broccolini et al., 2006). In
HIBM pathology it has been supposed that
hyposialylation would impair neprilysin stability and
enzymatic function, favoring the progressive
degenerative process of muscle fibers (Broccolini et al.,
2008, 2009, 2011; Jay et al., 2009; Malicdan et al., 2009;
Broccolini and Mirabella, 2015). The presence of SA on
other glycoproteic complex molecules, determinant for
muscle excitability, such as voltage-gated sodium and
potassium channels, was demonstrated to be important
for their activity modulation (Johnson et al., 2004; Jay et
al., 2009; Schwetz et al., 2011). SA may have an
important role in several other muscle glycoproteins too,
for example in conferring stability and acting as
scavenger of free radicals (Saito et al., 2004; Huizing
and Krasnewich, 2009; Malicdan et al., 2009). Other
investigations reported that the presence of SA in the
glycocalyx of the plasma membrane is necessary to
prevent uncontrolled entry of calcium into fibers (Jay et
al., 2008, 2009). In addition, gangliosides, richly
sialylated glycolipids, seem to be involved in regulation
of numerous cellular pathways in skeletal muscle, such
as proliferation, differentiation, hormone response,
trophic effect and control of apoptosis (Bruni and
Donati, 2008; Paccalet et al., 2010).
In view of the literature data, our findings on the
appearance and distribution of various monoSA types,
when probably a period of isolation, of contractility stop
and changes in cell biological processes occur, could
suggest their importance in the formation of functional
molecular complexes essential to complete the proper
human myogenesis and to prepare the muscle to a
correct functionality. It is noteworthy that from 11 wg,
when human mature myotubes are forming and
apoptosis is not more evident, besides an increase of
SAs, their sudden acetylation occurs. Some
investigations showed that acetylated SAs seem to have
important functions in embryogenesis, development,
immunological processes and in the regulation of
ganglioside-mediated apoptosis (Chen and Varki, 2002;
Malisan et al., 2002; Mandal et al., 2015). It has been
also seen that acetylation of different proteins could
protect from apoptosis through the Akt survival pathway
and controlling multiple apoptotic mediators (Yi et al.,
2011; Zacharias et al., 2011). We can speculate that
acetylation in fetal muscle could have a role in
stabilizing the structure of various sialylated molecules,




Another interesting finding arising from our study
regards the same appearance time and the same
expression of the various types of monoSAs in basement
membrane surrounding myotubes and myoblasts from 10
wg. Investigations on basement membrane in fetal
skeletal muscle, well developed from 11 wg (Fidziańska
and Goebel, 1991), demonstrated the important role of
this structure in various biological processes: scaffold for
promoting myogenesis and synaptogenesis, elastic
sheath around myotubes/myoblasts, improving plasma
membrane stability, assembly neuromuscular and
myotendineous areas, concentring growth factors for
myogenesis and probably many other processes
(Campbell and Stull, 2003; Sanes, 2003; Yurchenco,
2011). The components of basements that play a key role
in these functions are various glycoproteins and
proteoglycans such as laminin, fibronectin, collagen,
perlecan, agrin. Therefore, SA components in all or
some of these molecules could be essential for their
functionality. It is not excluded that acetylated SAs may
also play a role in basement membrane as a barrier for
extracellular apoptotic stimuli.
It is even to be kept in mind that some enzymatic
complexes are involved in SAs synthesis, transfer on
carbohydrate chain, addition of acetylic groups and
degradation (Krause et al., 2004; Varki and Schauer,
2009; Fanzani et al., 2012). In particular, investigations
on human myoblasts cell culture and on animal models
muscle tissue during myogenesis, modulation of GNE
(regulating sialyltransferases, in SA biosynthesis) and
sialidases have been demonstrated to be implied in
various processes, such as muscle integrity and activity,
myofiber development and sarcomere organization and
apoptosis (Krause et al., 2004; Milman Krentsis et al.,
2011; Fanzani et al., 2012; Daya et al., 2014). The action
of these enzymatic complexes seems to be strictly
correlated to that of myogenic factors (Anastasia et al.
2008; Milman Krentsis et al., 2011; Fanzani et al., 2012;
Daya et al., 2014). A functional inter-correlation
between SAs and myogenic factors during myogenesis
can be supposed, too. In future studies, it could be
interesting to investigate the expression of enzymatic
complexes and myogenic factors during the same
development period of human skeletal muscle examined
in the present study, to understand better the mechanisms
at the basis of myogenesis.
In conclusion, our findings showed changes in the
expression of the various types of SA investigated during
a short but important period of myogenesis. In particular,
PSA seems to determine separation and isolation of
myotubes and myoblasts to permit future and correct
muscle maturation. When PSA is disappearing,
monomeric SAs appearance, increase and changes in
structure (acetylation) could be implied in functionality
of molecular complexes important to lead towards a
complete and correct myogenesis. Sialylation changes in
various molecules during early stages of development
could contribute to altered myogenesis leading to HIBM
pathology (due to GNE gene mutation) but also to other
congenital myopathies whose causes are still not well
known (North et al., 2014). 
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